The Pioneer Of Seeking Alpha's BAD BEAT Investing, Quad 7 Capital is a team of 7 analysts with a wide range of experience sharing investment opportunities for nearly 12 years. They are best known for their February 2020 call to sell everything & go short, & have been on average 95% long 5% short since May 2020. The broader company has expertise in business, policy, economics, mathematics, game theory, & the sciences. They share both long & short trades & invest personally in equities they discuss within the ...

Key Takeaways Strategic acquisitions like LifeSync and CIT bolster APH's positioning in high-reliability sectors. The Andrew acquisition raised the FY accretion forecast from 6 cents to 9 cents per share. Stock is trending above its 50 and 200-day SMAs, reinforcing a bullish outlook ahead of earnings.Amphenol (APH) is set to report its second-quarter 2025 results on July 23.The company expects second-quarter 2025 earnings between 64 cents and 66 cents per share, indicating growth of 45% and 50% year over ...

5 ChatGPT Prompts To Delegate Your Work To AI And Hit The Beach https://t.co/lUlXufJyGz https://t.co/lUlXufJyGz ...

RT Chyan | chyan.base.eth (@Chyan)Smart money didn’t miss it this time — $BONK is the $HYPE rerun and they’re all in. 📈📢+157% in 30D to 11.8B bags on @nansen_ai — Bonk Guy called it, and big brains heeded this time.Missed @theunipcs #USELESS shout at the bottom. Glad I heard the bark on $BONK. 🧠🐶 https://t.co/vbDcejsC2N ...

RT BSCN (@BSCNews)AI PROTOCOL TO WATCH: THEORIQ - @TheoriqAI's Agent Swarm technology is at the forefront of CryptoAI innovation. Here's a full analysis https://t.co/MLS6YsuDxW ...

Core Viewpoint - Tevogen Bio Holdings Inc. has announced the publication of its international patent application for a machine learning-based technology aimed at identifying immunologically active peptides, which is crucial for developing targeted therapies for diseases like cancer and infections [1][2]. Group 1: Technology and Innovation - The patented technology utilizes machine learning algorithms, developed in collaboration with Microsoft and Databricks, to enhance the identification of peptides that interact strongly with the immune system [1]. - Traditional methods for identifying these peptides often overlook important genetic diversity factors, but Tevogen.AI's approach aims to address these limitations [2]. - The technology focuses on efficiently screening and ranking potential peptides based on their immunological activity and continuously refining predictions using real-world data [6]. Group 2: Strategic Goals - The company emphasizes the importance of leveraging artificial intelligence to accelerate discovery, shorten development timelines, and reduce costs in the context of personalized T cell therapies [2]. - The goal is to deliver commercially attractive and economically viable therapies for various diseases, including cancers and infectious diseases [2].

As one of the top technology enterprises in the world, Alphabet Inc. GOOG GOOGL will command a massive audience when it releases its second-quarter earnings report on Wednesday, July 23, after the closing bell. Analysts will be looking for earnings per share of $2.17 on revenue of $93.72 billion, a sizable lift from the year-ago quarter's print of $1.89 and $84.74 billion, respectively.Undoubtedly, artificial intelligence will represent a hot topic for Alphabet, which owns the Google ecosystem. Earlier this ...

Worried about AI taking your job? Discover five powerful ways to turn AI anxiety into an impressive salary boost. https://t.co/N9toSj7Dqz https://t.co/N9toSj7Dqz ...

Build the future of AI on Ethereum.Pond (@JoinPond):Building an AI startup and ready to launch?Join a 2-week virtual hackathon by Pond, @ElevenLabsDevs, @ethereumfndn & @googlecloud• Special partner prizes• Up to $50K in potential community-backed seeding• Launch your product to thousandsApply: https://t.co/XRuLUtQVhB https://t.co/5sMXBfX450 ...

Shares of Nvidia up about 5% since announcing that it does expect to be able to resume selling those H20 chips in China. A move that could add some fresh fuel for China's AI ambitions. For that, we'll turn to Dear Dosa today in today's Tech Check.Happy Friday, De. Hey, happy Friday. Good morning, Carl.So, the plus side for the US of this development is that the momentum will still run on American rails. With the H20s return, Nvidia, it remains the backbone of Chinese AI, not just through hardware, but throu ...